Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI
NCT00412126 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2006-12-15
Summary
Coronary artery disease is a process that results in "hardening of the arteries". When the arteries that supply blood and oxygen to your heart muscle become clogged or narrowed, a heart attack may result, or you may feel chest discomfort (angina) - sometimes even while resting. One approach to treating this condition is a balloon procedure known as coronary angioplasty.
The major limitation of coronary angioplasty is renarrowing of the artery (restenosis) in the first six months following the procedure requiring either repeat angioplasty or referral for bypass surgery. Patients with diabetes have always been identified as having higher rates of restenosis and poor outcomes following angioplasty, despite some important scientific advances. We think that the level of blood sugar control at the time of angioplasty and in the following months may be related to the extent of restenosis.
We expect that a reduction in blood sugar with insulin may, in turn, reduce the restenosis process and improve your long-term outcome.
Conditions
- Diabetes Mellitus
- Coronary Restenosis
Interventions
- DRUG
Sponsors & Collaborators
-
Heart and Stroke Foundation of Canada
collaborator OTHER -
Hamilton Health Sciences Corporation
lead OTHER
Principal Investigators
-
Madhu K Natarajan, MD, FRCPC · Hamilton Health Sciences Corporation
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-07-31
- Completion
- 2005-09-30
Countries
- Canada
Study Locations
More Related Trials
-
Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes
NCT03113773 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary Syndromes - IVORY
NCT04241601 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Tight Glycaemic Control in Acute Myocardial Infarction
NCT00237471 ·Status: TERMINATED ·Phase: PHASE4
-
The RECOVERY Study: Using Supersaturated Oxygen Therapy To Treat Small Vessel Blockages After a Heart Attack
NCT07000266 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Post Conditioning in PCI for Acute ST Elevation Myocardial Infarction
NCT00334373 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Acute Insulin Resistance on Myocardial Blush in Non- Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention
NCT04651842 ·Status: COMPLETED
-
Coronary Artery Endothelial Dysfunction With Drug Coated Balloons
NCT04901767 ·Status: COMPLETED
-
Delayed Postconditioning
NCT01483755 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Percutaneous Coronary Intervention in Patients With Cardiac Arrest After Acute Myocardial Infarction: a 2-Year Study
NCT02576691 ·Status: COMPLETED
-
Revascularization StrategIes for ST Elevation Myocardial Infarction Trial
NCT03263468 ·Status: UNKNOWN ·Phase: NA
-
Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 Hours
NCT00260416 ·Status: COMPLETED ·Phase: PHASE2
-
Symptomatic Trial of Angina Assessment Prior to Revascularization
NCT04280575 ·Status: COMPLETED
-
Complete vs Culprit-only Revascularization to Treat Multi-vessel Disease After Early PCI for STEMI
NCT01740479 ·Status: COMPLETED ·Phase: NA
-
Chronic Remote Ischemic Conditioning to Modify Post-MI Remodeling
NCT01817114 ·Status: UNKNOWN ·Phase: NA
-
Inflammatory and Hematological Indices in Diabetic STEMI Patients Undergoing Primary PCI
NCT07155395 ·Status: NOT_YET_RECRUITING
-
Postconditioning in Primary PCI and Direct Stenting
NCT00351247 ·Status: UNKNOWN ·Phase: NA
-
Vascular Basis for the Treatment of Ischemia
NCT00005681 ·Status: COMPLETED
-
The Efficacy of SGLT-2 Inhibitor in Patients With CAD and DM Undergoing PCI.
NCT05333159 ·Status: UNKNOWN
-
Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
NCT01882179 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of a Novel Adjunctive Pacing Strategy During Rotational Atherectomy
NCT05404204 ·Status: UNKNOWN
-
Henagliflozin Reducing Infarct Size After Priamry PCI in Patients With ST Segment Elevation Myocardial Infarction
NCT06187727 ·Status: COMPLETED ·Phase: PHASE4
-
Prognosis and Antiplatelet Strategies for Patients With PCI and High Bleeding Risk:A Study Protocol
NCT05369442 ·Status: RECRUITING
-
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
NCT00007657 ·Status: COMPLETED ·Phase: PHASE3
-
Upfront Premedication For Reduction of Microvascular Obstruction and No-reflow in Treating ST-segment Elevation Myocardial Infarction
NCT05393557 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Protective Effect of Coronary Collaterals on Infarct Size in Patients With Acute Myocardial Infarction
NCT00412672 ·Status: WITHDRAWN